2016
DOI: 10.1016/j.celrep.2015.12.045
|View full text |Cite
|
Sign up to set email alerts
|

Identifying Family-Member-Specific Targets of Mono-ARTDs by Using a Chemical Genetics Approach

Abstract: SUMMARY ADP-ribosyltransferases (ARTD1–16) have emerged as major downstream effectors of NAD+ signaling in the cell. Most ARTDs (ARTD7–8, 10–12, 14–17) catalyze the transfer of a single unit of ADP-ribose from NAD+ to target proteins, a process known as mono-ADP-ribosylation (MARylation). Progress in understanding the cellular functions of MARylation has been limited by the inability to identify the direct targets for individual mono-ARTDs. Here we engineered mono-ARTDs to use an NAD+ analogue that is orthogon… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
68
0
4

Year Published

2016
2016
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 75 publications
(75 citation statements)
references
References 27 publications
0
68
0
4
Order By: Relevance
“…However, we expect this trend will be changed soon with the coming-of-age technologies to investigate enzyme–substrate specificity of 17 human ADP-ribosyltransferases. These include proteome arrays (18,19), the development of analog-sensitive ADP-ribosyltransferases (4749) as well as the improvement in performing genetic knockdown by RNA interference and knockout using CRISPR in mammalian cell culture. Finally, PARP inhibition is actively used in clinical settings.…”
Section: Introductionmentioning
confidence: 99%
“…However, we expect this trend will be changed soon with the coming-of-age technologies to investigate enzyme–substrate specificity of 17 human ADP-ribosyltransferases. These include proteome arrays (18,19), the development of analog-sensitive ADP-ribosyltransferases (4749) as well as the improvement in performing genetic knockdown by RNA interference and knockout using CRISPR in mammalian cell culture. Finally, PARP inhibition is actively used in clinical settings.…”
Section: Introductionmentioning
confidence: 99%
“…Because these chemical linkages can be quite different, and many of the site identifications for PARPs appear to be dependent on the technique used to identify them, it is unclear which of the amino acids are the true sites of ADP-ribosylation in the cell. Combining recently developed strategies for finding the direct targets of MARylating PARPs with mass spectrometry methods to identify the aa-ADPr sites will help figure out the family-member-specific amino acid targeting preferences across multiple targets 50,76 . Indeed, a recent study combining a chemical–genetics strategy to identify targets of the nuclear PARPs (PARP1, PARP2, and PARP3) with a mass spectrometry method to identify aa-ADPr sites revealed potential family-member-specific consensus sequences 50 .…”
Section: Target Recognition and Amino Acid Selectionmentioning
confidence: 99%
“…This is mainly due to the labile bonds between ADP-ribose to the substrate, and the low abundance of this modification in steady state conditions. So far, chemical tools, such as NAD+ analogues, have been used for in vitro approaches, (Carter-O'Connell et al, 2016). Monitoring PARylation has been possible in vitro using the PAR affinity resin (Tulip-4301 www.tulipbiolabs.com/4301.html) and monoclonal antibodies, such as 10H and LP96-10.…”
Section: Introductionmentioning
confidence: 99%